Yu JC - Search Results

1

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.

Chen L, Rangel JDG, Cil T, Li X, Cicin I, Shen Y, Liu Z, Ozyilkan O, Igor B, Chen J, Oleksandr K, Chen Z, Zhang H, Fu Z, Dong Q, Song S, Yu JC, Zhang L. Chen L, et al. Among authors: yu jc. Cancer Med. 2023 Nov;12(22):20847-20863. doi: 10.1002/cam4.6664. Epub 2023 Nov 7. Cancer Med. 2023. PMID: 37935428 Free PMC article. Clinical Trial.

2

A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin^®) in Healthy Male Subjects.

Wu X, Wynne C, Xu C, Gan Y, Wang C, Thomas BE, Yu JC, Li S, Zhang L. Wu X, et al. Among authors: yu jc. BioDrugs. 2019 Jun;33(3):335-342. doi: 10.1007/s40259-019-00352-7. BioDrugs. 2019. PMID: 31016568 Clinical Trial.

3

Large-scale production, purification, and function of a tumor multi-epitope vaccine: Peptibody with bFGF/VEGFA.

Zhang L, Jiang C, Chen X, Gu J, Song Q, Zhong H, Xiong S, Dong Q, Yu JC, Deng N. Zhang L, et al. Among authors: yu jc. Eng Life Sci. 2020 Jul 29;20(9-10):422-436. doi: 10.1002/elsc.202000020. eCollection 2020 Sep. Eng Life Sci. 2020. PMID: 32944017 Free PMC article.

4

A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects.

Wu M, Sun J, Wu D, Xu J, Wei J, Wang Z, Yu J, Li S, Zhang H, Ding Y. Wu M, et al. Expert Opin Investig Drugs. 2021 Jan;30(1):77-83. doi: 10.1080/13543784.2021.1851364. Epub 2020 Nov 26. Expert Opin Investig Drugs. 2021. PMID: 33241960 Clinical Trial.

5

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.

Zhang H, Wang H, Wei H, Chen H, Liu J, Li C, Zhu X, Li X, Yu J, Zhou Y, Yang X, Wang Z, Wu M, Ding Y. Zhang H, et al. Front Pharmacol. 2021 Jan 25;11:609522. doi: 10.3389/fphar.2020.609522. eCollection 2020. Front Pharmacol. 2021. PMID: 33569002 Free PMC article.

6

Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial.

Wu M, Li X, Yang D, Wang M, Zhang H, Li C, Mai J, Yang L, Qi Y, Yu JC, Yang X, Wang Z, Gu C, Ding Y. Wu M, et al. Among authors: yu jc. BioDrugs. 2023 Jan;37(1):89-98. doi: 10.1007/s40259-022-00563-5. Epub 2022 Nov 22. BioDrugs. 2023. PMID: 36417156 Free PMC article. Clinical Trial.

7

BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy.

Liang S, Zheng D, Liu X, Mei X, Zhou C, Xiao C, Qin C, Yue H, Lin J, Liu C, Li S, Yu JC. Liang S, et al. Among authors: yu jc. Front Oncol. 2023 Jul 28;13:1211759. doi: 10.3389/fonc.2023.1211759. eCollection 2023. Front Oncol. 2023. PMID: 37576888 Free PMC article.

8

Rapid preparation of 1-vinylimidazole based non-affinity polymers for the highly-selective purification of antibodies from multiple biological sources.

Lei Y, Liu X, Lu L, Liu C, Xu R, Huang S, Shen Y, Deng C, Yu J, Zhang T, Crommen J, Wang Q, Jiang Z. Lei Y, et al. J Chromatogr A. 2020 Nov 22;1632:461607. doi: 10.1016/j.chroma.2020.461607. Epub 2020 Oct 11. J Chromatogr A. 2020. PMID: 33080535

9

Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report.

Chang YK, Chen YY, Hong ZJ, Liao GS, Yu JC. Chang YK, et al. Among authors: yu jc. Clin Case Rep. 2024 Dec 12;12(12):e9639. doi: 10.1002/ccr3.9639. eCollection 2024 Dec. Clin Case Rep. 2024. PMID: 39677870 Free PMC article.

10

Multiepitope recognition technology promotes the in-depth analysis of antibody‒drug conjugates.

Lei Y, Shen Y, Chen F, He R, Zhang Z, Zhou Y, Yu JC, Crommen J, Jiang Z, Wang Q. Lei Y, et al. Among authors: yu jc. Acta Pharm Sin B. 2024 Nov;14(11):4962-4976. doi: 10.1016/j.apsb.2024.06.007. Epub 2024 Jun 19. Acta Pharm Sin B. 2024. PMID: 39664422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,009 results

Search Page

Filters